Today: 29 June 2026
Browse Category

NYSEA:UEC 10 December 2025 - 16 January 2026

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines shares rose about 4.1% to $3.70 Friday morning, trading as high as $3.80, as uranium stocks advanced. Cameco gained 3.8% and Uranium Energy jumped 4.6%. Investors are watching for final approvals on Denison’s Phoenix uranium mine in Canada, which could start construction this year. Around 7.3 million Denison shares changed hands by mid-morning.
16 January 2026
·····
UEC stock jumps 12% as uranium miners rally into 2026 — what traders watch next

UEC stock jumps 12% as uranium miners rally into 2026 — what traders watch next

Uranium Energy Corp shares surged 12.2% to $13.11 on Friday, tracking a broad rally in uranium miners after Denison Mines announced readiness to start construction on its Phoenix ISR project. Denison’s Toronto shares jumped 13.7%, while Energy Fuels rose 15.4%. Uranium Energy’s stock remains below its 52-week high of $17.80. Trading volume reached 9 million shares, under its daily average.
4 January 2026
·
Uranium Energy Corp (UEC) Stock Falls After Q1 2026 Earnings – Fresh Results, Price Targets and Uranium Market Outlook (10 December 2025)

Uranium Energy Corp (UEC) Stock Falls After Q1 2026 Earnings – Fresh Results, Price Targets and Uranium Market Outlook (10 December 2025)

Uranium Energy Corp shares fell 6–7% to around $13.08 after reporting no revenue and a net loss of $10.3 million for fiscal Q1 2026. The company did not sell uranium during the quarter, focusing instead on expanding production capacity and inventory. UEC completed the Sweetwater acquisition in 2025 and now holds over 1.3 million pounds of uranium in inventory.
10 December 2025
··

Stock Market Today

  • Fluor's Russell Index Additions and Pharma Feasibility Studies Could Shift Investment Outlook
    June 29, 2026, 12:41 AM EDT. Fluor Corporation (NYSE: FLR) was added to multiple Russell growth indexes in June 2026, boosting its visibility in key equity benchmarks. Concurrently, it began feasibility studies for Voyageur Pharmaceuticals on an iodine project linked to Bayer and a new contrast media manufacturing facility in North America. These moves might broaden Fluor's market exposure beyond its traditional engineering and construction segments. While the developments support Fluor's backlog and diversification story, analysts caution the near-term focus remains on managing execution risks and cash flow volatility. Fluor projects $18.3 billion revenue and $443.4 million earnings by 2029, requiring steady growth amid potential cost and labor challenges. Investor opinions vary, with some seeing upside potential beyond current valuations, while others stress caution due to operational risks.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop